This volume addresses the content of television -- both programs and advertisements -- and the psychological effects of the content on the audience. The author not only reports new research, but explains its practical applications without jargon. Issues are discussed and described in terms of psychological mechanisms and causal routes of influence. While primarily referring to the American television industry and American governmental regulations, the psychological principles discussed are applicable to television viewers world wide.
Outbreaks of Ebola, SARS, MERS, coronavirus, and pandemic influenza are brutal reminders of the dangers of infectious disease. Comparing the development of disease control in Britain and the United States, from the 1793 yellow fever outbreak in Philadelphia to the H1N1 panics of more recent times, Diseased States provides a blueprint for managing pandemics in the twenty-first century. To understand why these two nations have handled contemporary disease threats in such different ways, Charles Allan McCoy examines when and how disease control measures were adopted in each country from the nineteenth century onward, which medical theory of disease was dominant at the time, and where disease control was located within the state apparatus. Particular starting conditions put Britain and the United States on distinct trajectories of institutionalization that led to their respective systems of disease control. As McCoy shows, even the seemingly objective matter of contagion is deeply enmeshed in social and political realities, and by developing unique systems of biopower to control the spread of disease, Britain and the United States have established different approaches of exerting political control over citizens' lives and bodies.
- NEW chapter: Indigenous Insights into Nursing and Midwifery Research - NEW chapter: Navigating Nursing and Midwifery Research Ethics - NEW chapter: Knowledge Translation of Research Findings: Challenges and Strategies - A significantly expanded glossary to encompass the widening scope of nursing research.
Glenn's Urologic Surgery is a comprehensive but concise textbook focused on surgical procedures. After more than 30 years it is still required reading for most urology residents and is consulted by practicing physicians while planning surgeries. Chapters are heavily illustrated and progress from diagnosis to indications for surgery, to brief sections on alternative therapies, and then to detailed sections on surgical technique before closing with a discussion of outcomes as found in the literature. The Seventh Edition continues to emphasize laparoscopic procedures. Each section opens with a thoroughly illustrated description of relevant anatomy.
This report presents key findings and recommendations based upon research conducted in 2011 by the Indigenous Legal Needs Project (ILNP) in the Northern Territory, Australia.The ILNP aims broadly and on a national level to: identify and analyze the legal needs of Indigenous communities in non-criminal areas of law (including discrimination, housing and tenancy, child protection, employment, credit and debt, wills and estates, and consumer-related matters); and provide an understanding of how legal service delivery might work more effectively to address identified civil and family law needs of Indigenous communities.
The enormous advances in the immunologic aspects of biotherapeutics and nanomedicines in the past two decades has necessitated an authoritative and comprehensive reference source that can be relied upon by immunologists, biomedical researchers, clinicians, pharmaceutical companies, regulators, venture capitalists, and policy makers alike. This text provides a thorough understanding of immunology, therapeutic potential, clinical applications, adverse reactions, and approaches to overcoming immunotoxicity of biotherapeutics and nanomedicines. It also tackles critical, yet often overlooked topics such as immune aspects of nano-bio interactions, current FDA regulatory guidances, complement activation-related pseudoallergy (CARPA), advances in nanovaccines, and immunogenicity testing of protein therapeutics.
